Incremental cost-effectiveness ratio

From WikiMD's WELLNESSPEDIA

Incremental cost-effectiveness ratio (ICER) is a statistic used in health economics to summarize the cost-effectiveness of a health care intervention. It is defined by the difference in cost between two possible interventions, divided by the difference in their effect. It represents the average incremental cost associated with 1 additional unit of the measure of effect.

Calculation[edit]

The ICER is calculated by the formula:

ICER = (C1 - C0) / (E1 - E0)

where C1 and C0 are the costs of the two interventions, and E1 and E0 are their effects. The ICER can be interpreted as the additional cost per additional unit of effect.

Interpretation[edit]

The ICER is used to compare the cost-effectiveness of two interventions. If the ICER is less than a predetermined threshold, the intervention is considered cost-effective. The threshold can vary depending on the country and the specific health care context.

Limitations[edit]

The ICER has several limitations. It assumes that the costs and effects of the interventions are linear and can be accurately estimated. It also does not take into account other factors that may be important in decision making, such as equity, feasibility, and acceptability.

See also[edit]

References[edit]


This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.